Feasibility Study of Occupation-Based 'Remediation, Education, Adaptation, Promotion' (REAP) Program Among People With Stroke in Bang

November 26, 2025 updated by: Azharul Islam, Tokyo Metropolitan University

Stroke causes major disability issues in Bangladesh and often leaves people unable to look after themselves, work, or participate in family and community life. Most stroke survivors in Bangladesh do not receive adequate rehabilitation, and existing services focus mainly on physical exercises, not on helping people return to meaningful activities.

The REAP programme is a new therapy approach that remediates skills through structured training, educates patients and families on stroke management, adapts tasks or environments to make daily activities easier, and promotes participation in meaningful roles and activities.

This study will test whether the REAP programme can be delivered successfully in a Bangladeshi rehabilitation centre, whether patients find it acceptable, and whether it helps people become more independent and improves quality of life.

Study Overview

Status

Active, not recruiting

Conditions

Study Type

Interventional

Enrollment (Actual)

6

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Dhaka, Bangladesh
        • Centre for the Rehabilitation of the Paralysed (CRP)

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult
  • Older Adult

Accepts Healthy Volunteers

No

Description

Inclusion Criteria:

  • Aged 18-64 years,
  • Diagnosed with stroke (ischemic/hemorrhagic) 3-24 months prior,
  • Medically stable and able to provide informed consent,
  • MoCA score ≥18.

Exclusion Criteria:

  • Severe receptive aphasia,
  • Major psychiatric disorders,
  • Unstable medical conditions

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Non-Randomized
  • Interventional Model: Single Group Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Stroke patients who are taking rehabilitation
Stroke patients aged 18-64 years, diagnosed with stroke (ischemic/hemorrhagic) 3-6 months prior, medically stable and able to provide informed consent, MoCA score ≥18.

The REAP program consists of four core components designed to address the complex needs of stroke survivors:

  1. Remediation
  2. Education
  3. Adaptation
  4. Promotion

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Barthel Index
Time Frame: From enrollment to 12 weeks
Assesses independence in activities of daily living (ADLs).
From enrollment to 12 weeks
Montreal Cognitive Assessment (MoCA)
Time Frame: Enrollment to 12 weeks
Screens for cognitive impairment.
Enrollment to 12 weeks
Bangladeshi Occupational Self-Assessment - Short Form (BOSA-SF) (
Time Frame: Enrollment to 12 weeks
Evaluates perceived occupational competence and values within the local context.
Enrollment to 12 weeks
Fugl-Meyer Assessment (FMA)
Time Frame: Enrollment to 12 weeks
Assesses motor recovery post-stroke
Enrollment to 12 weeks
Occupational Balance Questionnaire
Time Frame: Enrollment to 12 weeks
Measures balance between different occupational areas in everyday life.
Enrollment to 12 weeks
Life Satisfaction Questionnaire (LiSat-11)
Time Frame: Enrollment to 12 weeks
Assesses subjective life satisfaction across various domains
Enrollment to 12 weeks
Zarit Caregiver Burden Scale
Time Frame: Enrollment to 12 weeks
Assesses the level of burden experienced by informal caregivers
Enrollment to 12 weeks

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Study Director: Peter Bontje, PhD, Tokyo Metropolitan University

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

October 20, 2025

Primary Completion (Estimated)

December 20, 2025

Study Completion (Estimated)

March 30, 2026

Study Registration Dates

First Submitted

November 26, 2025

First Submitted That Met QC Criteria

November 26, 2025

First Posted (Estimated)

December 9, 2025

Study Record Updates

Last Update Posted (Estimated)

December 9, 2025

Last Update Submitted That Met QC Criteria

November 26, 2025

Last Verified

November 1, 2025

More Information

Terms related to this study

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Stroke

Clinical Trials on Occupation-Based 'Remediation, Education, Adaptation, Promotion' (REAP) Program

Subscribe